1-19 of 19
Vered Stearns
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11

Vered Stearns, Opeyemi A. Jegede, Victor T.-S. Chang, Todd C. Skaar, Jeffrey L. Berenberg, Ranveer Nand, Atif Shafqat, Nisha L. Jacobs, William Luginbuhl, Paul Gilman, Al B. Benson, III, Judie R. Goodman, Gary L. Buchschacher, Jr, N. Lynn Henry, Charles L. Loprinzi, Patrick J. Flynn, Edith P. Mitchell, Michael J. Fisch, Joseph A. Sparano, Lynne I. Wagner
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (13): 2709–2718.
https://doi.org/10.1158/1078-0432.CCR-23-2137
Published: 01 July 2024
View article titled, A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
Open the PDF for A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11 in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

Evanthia T. Roussos Torres, Christine Rafie, Chenguang Wang, David Lim, Adam Brufsky, Patricia LoRusso, Joseph Paul Eder, Vincent Chung, Melinda Downs, Molly Geare, Richard Piekarz, Howard Streicher, Leslie Anforth, Michelle A. Rudek, Qingfeng Zhu, Sepideh Besharati, Ashley Cimino-Mathews, Robert A. Anders, Vered Stearns, Elizabeth M. Jaffee, Roisin M. Connolly
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 5828–5837.
https://doi.org/10.1158/1078-0432.CCR-20-5017
Published: 01 November 2021
View article titled, Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)
Open the PDF for Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844) in another window
Includes: Supplementary data
Journal Articles

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)

Shannon L. Puhalla, Véronique Diéras, Banu K. Arun, Bella Kaufman, Hans Wildiers, Hyo S. Han, Jean-Pierre Ayoub, Vered Stearns, Yuan Yuan, Teresa Helsten, Bridget Riley-Gillis, Erin Murphy, Madan G. Kundu, Meijing Wu, David Maag, Christine K. Ratajczak, Cyril Y. Ramathal, Michael Friedlander
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 4983–4993.
https://doi.org/10.1158/1078-0432.CCR-21-0748
Published: 15 September 2021
View article titled, Relevance of Platinum-free Interval and <em>BRCA</em> Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g<em>BRCA</em> Advanced Breast Cancer (BROCADE3 Crossover)
Open the PDF for Relevance of Platinum-free Interval and <em>BRCA</em> Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g<em>BRCA</em> Advanced Breast Cancer (BROCADE3 Crossover) in another window
Includes: Supplementary data
Journal Articles

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer

Siang-Boon Koh, Kenneth Ross, Steven J. Isakoff, Nsan Melkonjan, Lei He, Karina J. Matissek, Andrew Schultz, Erica L. Mayer, Tiffany A. Traina, Lisa A. Carey, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Adam Langenbucher, Srinivas Vinod Saladi, Sridhar Ramaswamy, Michael S. Lawrence, Leif W. Ellisen
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4883–4897.
https://doi.org/10.1158/1078-0432.CCR-21-0714
Published: 01 September 2021
View article titled, RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
Open the PDF for RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial

Cesar A. Santa-Maria, Janelle W. Coughlin, Dipali Sharma, Mary Armanios, Amanda L. Blackford, Colleen Schreyer, Arlene Dalcin, Ashley Carpenter, Gerald J. Jerome, Deborah K. Armstrong, Madhu Chaudhry, Gary I. Cohen, Roisin M. Connolly, John Fetting, Robert S. Miller, Karen L. Smith, Claire Snyder, Andrew Wolfe, Antonio C. Wolff, Chiung-Yu Huang, Lawrence J. Appel, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 3024–3034.
https://doi.org/10.1158/1078-0432.CCR-19-2935
Published: 15 June 2020
View article titled, The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
Open the PDF for The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial in another window
Includes: Supplementary data
Journal Articles

Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis

Melinda L. Telli, Charles Chu, Sunil S. Badve, Shaveta Vinayak, Daniel P. Silver, Steven J. Isakoff, Virginia Kaklamani, William Gradishar, Vered Stearns, Roisin M. Connolly, James M. Ford, Joshua J. Gruber, Sylvia Adams, Judy Garber, Nadine Tung, Chris Neff, Ryan Bernhisel, Kirsten M. Timms, Andrea L. Richardson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2704–2710.
https://doi.org/10.1158/1078-0432.CCR-19-0664
Published: 01 June 2020
View article titled, Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <em>BRCA1/2</em> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis
Open the PDF for Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <em>BRCA1/2</em> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis in another window
Journal Articles

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Roisin M. Connolly, Huili Li, Rachel C. Jankowitz, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon A. Slater, Penny Powers, Antonio C. Wolff, John H. Fetting, Adam Brufsky, Richard Piekarz, Nita Ahuja, Peter W. Laird, Hui Shen, Daniel J. Weisenberger, Leslie Cope, James G. Herman, George Somlo, Agustin A. Garcia, Peter A. Jones, Stephen B. Baylin, Nancy E. Davidson, Cynthia A. Zahnow, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11): 2691–2701.
https://doi.org/10.1158/1078-0432.CCR-16-1729
Published: 31 May 2017
View article titled, Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Open the PDF for Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study in another window
Includes: Supplementary data
Journal Articles

Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer

Heather A. Parsons, Julia A. Beaver, Ashley Cimino-Mathews, Siraj M. Ali, Jennifer Axilbund, David Chu, Roisin M. Connolly, Rory L. Cochran, Sarah Croessmann, Travis A. Clark, Christopher D. Gocke, Stacie C. Jeter, Mark R. Kennedy, Josh Lauring, Justin Lee, Doron Lipson, Vincent A. Miller, Geoff A. Otto, Gary L. Rosner, Jeffrey S. Ross, Shannon Slater, Philip J. Stephens, Dustin A. VanDenBerg, Antonio C. Wolff, Lauren E. Young, Daniel J. Zabransky, Zhe Zhang, Jane Zorzi, Vered Stearns, Ben H. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 379–386.
https://doi.org/10.1158/1078-0432.CCR-16-1543
Published: 15 January 2017
View article titled, Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer
Open the PDF for Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

Cesar A. Santa-Maria, Amanda Blackford, Anne T. Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich, James M. Rae, Zeruesenay Desta, Jason Robarge, Norah Lynn Henry, Anna M. Storniolo, Daniel F. Hayes, Roger S. Blumenthal, Pamela Ouyang, Wendy S. Post, David A. Flockhart, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (6): 1395–1402.
https://doi.org/10.1158/1078-0432.CCR-15-1213
Published: 14 March 2016
View article titled, Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy
Open the PDF for Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate

Preethi Korangath, Wei Wen Teo, Helen Sadik, Liangfeng Han, Noriko Mori, Charlotte M. Huijts, Flonne Wildes, Santosh Bharti, Zhe Zhang, Cesar A. Santa-Maria, Hualing Tsai, Chi V. Dang, Vered Stearns, Zaver M. Bhujwalla, Saraswati Sukumar
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3263–3273.
https://doi.org/10.1158/1078-0432.CCR-14-1200
Published: 14 July 2015
View article titled, Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Open the PDF for Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate in another window
Includes: Supplementary data
Journal Articles

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Julia A. Beaver, Danijela Jelovac, Sasidharan Balukrishna, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Brian G. Blair, David Chu, Timothy Burns, Michaela J. Higgins, Vered Stearns, Lisa Jacobs, Mehran Habibi, Julie Lange, Paula J. Hurley, Josh Lauring, Dustin A. VanDenBerg, Jill Kessler, Stacie Jeter, Michael L. Samuels, Dianna Maar, Leslie Cope, Ashley Cimino-Mathews, Pedram Argani, Antonio C. Wolff, Ben Ho Park
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (10): 2643–2650.
https://doi.org/10.1158/1078-0432.CCR-13-2933
Published: 14 May 2014
View article titled, Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Open the PDF for Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Ayca Gucalp, Sara Tolaney, Steven J. Isakoff, James N. Ingle, Minetta C. Liu, Lisa A. Carey, Kimberly Blackwell, Hope Rugo, Lisle Nabell, Andres Forero, Vered Stearns, Ashley S. Doane, Michael Danso, Mary Ellen Moynahan, Lamia F. Momen, Joseph M. Gonzalez, Arooj Akhtar, Dilip D. Giri, Sujata Patil, Kimberly N. Feigin, Clifford A. Hudis, Tiffany A. Traina
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19): 5505–5512.
https://doi.org/10.1158/1078-0432.CCR-12-3327
Published: 01 October 2013
View article titled, Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer
Open the PDF for Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer

Vered Stearns, Lisa K. Jacobs, MaryJo Fackler, Theodore N. Tsangaris, Michelle A. Rudek, Michaela Higgins, Julie Lange, Zandra Cheng, Shannon A. Slater, Stacie C. Jeter, Penny Powers, Susanne Briest, Calvin Chao, Carl Yoshizawa, Elizabeth Sugar, Igor Espinoza-Delgado, Saraswati Sukumar, Edward Gabrielson, Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 4008–4016.
https://doi.org/10.1158/1078-0432.CCR-13-0033
Published: 15 July 2013
View article titled, Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
Open the PDF for Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood

Michaela J. Higgins, Danijela Jelovac, Evan Barnathan, Brian Blair, Shannon Slater, Penny Powers, Jane Zorzi, Stacie C. Jeter, George R. Oliver, John Fetting, Leisha Emens, Carol Riley, Vered Stearns, Frank Diehl, Philipp Angenendt, Peng Huang, Leslie Cope, Pedram Argani, Kathleen M. Murphy, Kurtis E. Bachman, Joel Greshock, Antonio C. Wolff, Ben H. Park
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (12): 3462–3469.
https://doi.org/10.1158/1078-0432.CCR-11-2696
Published: 14 June 2012
View article titled, Detection of Tumor <em>PIK3CA</em> Status in Metastatic Breast Cancer Using Peripheral Blood
Open the PDF for Detection of Tumor <em>PIK3CA</em> Status in Metastatic Breast Cancer Using Peripheral Blood in another window
Includes: Supplementary data
Journal Articles

Personalized Tamoxifen: A Step Closer but Miles To Go

Aditya Bardia, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (17): 4308–4310.
https://doi.org/10.1158/1078-0432.CCR-10-1506
Published: 31 August 2010
View article titled, Personalized Tamoxifen: A Step Closer but Miles To Go
Open the PDF for Personalized Tamoxifen: A Step Closer but Miles To Go in another window
Includes: Supplementary data
Journal Articles

A Pilot Study to Establish a Clinical Model to Perform Phase II Studies of Breast Cancer Chemopreventive Agents in Women at High Risk with Biomarkers as Surrogate Endpoints for Activity

Vered Stearns, Ann Gallagher, Celina G. Kleer, Baljit Singh, Matthew Freedman, Bassem R. Haddad, Claudine Isaacs, Robert Warren, Martha Brown, Jennifer Cullen, Bruce Trock, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8332–8340.
https://doi.org/10.1158/1078-0432.CCR-04-0297
Published: 28 December 2004
View article titled, A Pilot Study to Establish a Clinical Model to Perform Phase II Studies of Breast Cancer Chemopreventive Agents in Women at High Risk with Biomarkers as Surrogate Endpoints for Activity
Open the PDF for A Pilot Study to Establish a Clinical Model to Perform Phase II Studies of Breast Cancer Chemopreventive Agents in Women at High Risk with Biomarkers as Surrogate Endpoints for Activity in another window
Journal Articles

A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia

Vered Stearns, Andrew Coop, Baljit Singh, Ann Gallagher, Hideko Yamauchi, Ronald Lieberman, Marie Pennanen, Bruce Trock, Daniel F. Hayes, Matthew J. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (22): 7583–7591.
https://doi.org/10.1158/1078-0432.CCR-04-0295
Published: 29 November 2004
View article titled, A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia
Open the PDF for A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia in another window
Journal Articles

A Prospective Randomized Pilot Study to Evaluate Predictors of Response in Serial Core Biopsies to Single Agent Neoadjuvant Doxorubicin or Paclitaxel for Patients with Locally Advanced Breast Cancer

Vered Stearns, Baljit Singh, Theodore Tsangaris, Jeanette G. Crawford, Antonella Novielli, Mathew J. Ellis, Claudine Isaacs, Marie Pennanen, Cecilia Tibery, Ahmad Farhad, Rebecca Slack, Daniel F. Hayes
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 124–133.
Published: 01 January 2003
View article titled, A Prospective Randomized Pilot Study to Evaluate Predictors of Response in Serial Core Biopsies to Single Agent Neoadjuvant Doxorubicin or Paclitaxel for Patients with Locally Advanced Breast Cancer
Open the PDF for A Prospective Randomized Pilot Study to Evaluate Predictors of Response in Serial Core Biopsies to Single Agent Neoadjuvant Doxorubicin or Paclitaxel for Patients with Locally Advanced Breast Cancer in another window
Journal Articles

Development and Validation of a Method for Using Breast Core Needle Biopsies for Gene Expression Microarray Analyses

Matthew Ellis, Natalie Davis, Andrew Coop, Minetta Liu, Lisa Schumaker, Richard Y. Lee, Rujirutana Srikanchana, Chris G. Russell, Baljit Singh, William R. Miller, Vered Stearns, Marie Pennanen, Theodore Tsangaris, Ann Gallagher, Aiyi Liu, Alan Zwart, Daniel F. Hayes, Marc E. Lippman, Yue Wang, Robert Clarke
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1155–1166.
Published: 01 May 2002
View article titled, Development and Validation of a Method for Using Breast Core Needle Biopsies for Gene Expression Microarray Analyses
Open the PDF for Development and Validation of a Method for Using Breast Core Needle Biopsies for Gene Expression Microarray Analyses in another window